Mark R. Gilbert

49.4k citations
491 papers · 24.8k indexed · 9 hit papers · h-index 77

Mark R. Gilbert

474 papers receiving 24.4k citations

Hit Papers

IDH mutation in glioma: mol...426200820262014202050010001.5k2.0k2.5k

Peers

Mark R. Gilbert
Comparison fields: 5 of 168
  • Genetics 15.1k
  • Cancer Research 4.5k
  • Oncology 5.9k
  • Pulmonary and Respiratory Medicine 6.8k
  • Neurology 2.7k
Replace Christine Marosi with:
Christine Marosi Austria
Martin Taphoorn Netherlands
R.O. Mirimanoff Switzerland
Thierry Gorlia Belgium
Allan H. Friedman United States
Michael D. Prados United States
Kenneth Aldape United States
Anouk Allgeier Netherlands
Alba A. Brandes Italy
Warren Mason Canada
Mark R. Gilbert relative to Christine Marosi Austria Christine Marosi's profile →
Citations per field
00.5×1.5×
Christine Marosi · 1×
Citations per year

Countries citing papers authored by Mark R. Gilbert

Since Specialization
Citations

This map shows the geographic impact of Mark R. Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Gilbert more than expected).

Fields of papers citing papers by Mark R. Gilbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Gilbert. The network helps show where Mark R. Gilbert may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark R. Gilbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark R. Gilbert Line = papers co-authored together Mark R. Gilbert links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 202411
3 202323
4 20220
5 20212
6 202114
7 202037
8 20201
9 201969
10 201890
11 2017161
12 2016131
13 201527
14
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trialbreakdown →
2013742
15 2012231
16 2011168
17 201151
18
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastomabreakdown →
2010613
19 2005201
20
Irinotecan: promising activity in the treatment of malignant glioma.
200318

About Mark R. Gilbert

Mark R. Gilbert is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Neurology, having authored 491 papers that have together received 24.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (315 papers), Brain Metastases and Treatment (114 papers), Cancer Immunotherapy and Biomarkers (33 papers), Cancer, Hypoxia, and Metabolism (32 papers), Cancer Treatment and Pharmacology (31 papers), Neuroblastoma Research and Treatments (29 papers), Meningioma and schwannoma management (29 papers) and Radiomics and Machine Learning in Medical Imaging (27 papers). The work is most often cited by research in Genetics (15.1k citations), Cancer Research (4.5k citations), Oncology (5.9k citations), Pulmonary and Respiratory Medicine (6.8k citations) and Neurology (2.7k citations). Mark R. Gilbert has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Terri S. Armstrong, Minesh P. Mehta, Kenneth Aldape, Roger Stupp, Patrick Y. Wen, Wolfgang Wick, David A. Reardon, Kathleen R. Lamborn, Timothy F. Cloughesy and Monika E. Hegi. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Journal of Neuro-Oncology, Current Oncology Reports and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026